Live from ESC in Munich, Lisa Salberg and Dr. Martin Maron unpack groundbreaking results from the ACACIA-HCM trial and what they could mean for people with nonobstructive HCM. They discuss…
Lisa Salberg and Dr. Michael Ayres discuss how patients and families can recognize changing HCM symptoms and know when to call their care team or seek urgent help. They also tackle back-to-school…
Lisa Salberg and Dr. Martin Maron take a fresh look at the long-standing role of beta blockers in HCM and how newer myosin inhibitors are changing the treatment conversation. They also discuss…
Lisa Salberg and Dr. Martin Maron explore new directions in HCM care, including emerging therapies targeting cardiac fibrosis and what researchers are learning about scarring in the heart. They also…
Lisa Salberg and Dr. Alex de Feria explore the growing HCM treatment toolbox, including the innovative SESAME procedure, emerging clinical trials and new possibilities for patients. They also tackle…
Lisa Salberg sits down with whistleblower Dinesh Thaker to examine the hidden risks within the generic drug supply chain and why stronger oversight is urgently needed. Together, they discuss drug…
Lisa Salberg and Dr. Steve Ommen discuss practical ways to stay healthy with HCM during the busy summer months. They also break down promising new drug research, explain what emerging biomarkers mean…
Lisa Salberg sits down with Dr. Nicholas Smedira of the Cleveland Clinic to explore how HCM surgery has evolved over the past three decades. They discuss myectomy, myosin inhibitors, surgical…
Lisa Salberg welcomes Dr. Ahmed "Sami" Abuzaid to discuss the growth of specialized HCM care in Alaska. They explore building a regional HCM program, expanding access to clinical trials, improving…
Lisa Salberg welcomes Dr. Christopher Kramer to discuss groundbreaking findings from the international HCMR Registry. They explore how cardiac MRI, scar burden, heart muscle mass, and biomarkers may…
